New drug aims to free patients from daily pill burden
NCT ID NCT07299838
Summary
This study followed 90 adults in Greece with chronic hypoparathyroidism, a condition where the body struggles to regulate calcium. It tested a new drug called palopegteriparatide to see if it could effectively control the disease and allow patients to stop taking daily calcium and vitamin D supplements. Researchers tracked how long it took patients to become independent from these supplements and monitored their safety and blood calcium levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOPARATHYROIDISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Laiko General Hospital
Athens, Attica, 11527, Greece
Conditions
Explore the condition pages connected to this study.